ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

STX Shield Therapeutics Plc

1.35
0.125 (10.20%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.125 10.20% 1.35 1.30 1.40 1.35 1.20 1.23 8,345,835 16:20:04
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.26 10.47M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 1.23p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £10.47 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.26.

Shield Therapeutics Share Discussion Threads

Showing 7651 to 7674 of 23175 messages
Chat Pages: Latest  315  314  313  312  311  310  309  308  307  306  305  304  Older
DateSubjectAuthorDiscuss
28/1/2021
22:26
This guy Tim . Is living in a dream. He has his head so much up,, His own Ass. Can not see the wood for the trees. By the time he gets to market he be collecting his pension. Lol .. He needs to go back to school To the do his business studies . As he has not got a clue ..
goforgold1
28/1/2021
21:25
Why is he even mentioning specific prices? If he'd just do his job properly the share price will take care if itself.
lako42
28/1/2021
16:29
Just listened to Tim on VOX and it was the most fluent I’ve heard him but I would just like to comment on one remark which I found Flabbergasting.
He is clearly of the opinion the share fall as been overdone but he suggests that on a USA licensing deal the share price should get back to £1.20 range if not a little more is he not aware that 12 months ago we were trading at £1.70 in anticipation of a deal which you would of imagined would have driven the valuation above £2 it was just a crazy remark

best1467
28/1/2021
13:13
We all know TW isnt the world's best presenter but his performance on the podcast was fine. Definitely not "poor".
t0pgrader
28/1/2021
11:04
I guess you prbably know this... generally anything he/they have done from an IR perspective will be found on hxxps://www.shieldtherapeutics.com/investors/. This includes recent presentations, interviews (such as those with Proactive) and/or podcasts (Vox Markets) etc...
innittowinit
28/1/2021
09:06
do you have a link to the podcast please?
t0pgrader
28/1/2021
02:01
Poor podcast with Mr waites.
letmepass
27/1/2021
22:54
Told you all 45p
goforgold1
27/1/2021
20:34
Looking like lower lows on the chart. Sub 50p coming
letmepass
26/1/2021
21:25
Massive move coming.....if not...all Technical Analysis principles which have not failed me for years are completely wrong for the very first time.

Don’t get me wrong, the minor moves can be 70/30, but not the big longer timescale moves. All major methodologies are pointing to a Mkt Cap significantly North of where we are today.

hodhasharon
26/1/2021
21:18
Second day running someone's building!//
bobaxe1
26/1/2021
19:08
A rapid rise from here is inevitable considering the options spelled out already. We have noted big buys throughout the past few days/weeks including Directors. The BOD's back is against the wall and they have to deliver this time, no more ifs/buts. They have to pull out all the stops. I believe they will before end of Q1. Fingers crossed and staying positive as they have a great product for the present and future market. Could there be an offer from the IV market leader???
frrinvest
26/1/2021
18:01
450,000 buys after hours
t0pgrader
26/1/2021
14:58
Sng has already paid out twice, but I know what you mean. Be nice if this paid out too !//
bobaxe1
26/1/2021
14:24
If/when SNG pays out I will be buying back in if the price remains sub £1. GLA.
adman50
26/1/2021
12:30
hxxps://www.ii.co.uk/analysis-commentary/insider-shield-therapeutics-duo-bet-us-success-ii514874

Thanks t0pgrader for highlighting

growthinvestor2001
25/1/2021
19:04
500,000 shares bt 4-5pm today vs insignificant sells
t0pgrader
25/1/2021
18:43
25th Jan 2021 interactive investor feature an article on STX entitled "Insider: Shield Therapeutics duo bet on US success"
t0pgrader
25/1/2021
10:41
Finding difficult to buy.

With my broker I don't usually have any probs buying but this time no. Looks like shares are being hoovered up.

frrinvest
24/1/2021
01:17
Read the words... what I said was it depends on which way the rerating goes. If someone chooses to infer that was downwards then that's your choice... I didn't.

I am a holder and have been since mid 2018 and remain so - having known a couple of people with IBD related anaemia who very clearly benefitted from the product. Thanks to the good work the company has previously done from a development persepctive as well as in the IR/PR area, I have been able to adjust my position over that time when there have been opportunities to take profit, but fortunately continue to be significantly above my average in price and hope the company gets itself sorted and the share price responds accordingly as I continue to think Feraccru is an excellent product. However I simply think the current BOD and management are just not up to the job, which I believe has been well evidenced over the last few months, so have recently posted a few comments to hopefully engender some thoughtful debate around that.

C'est la vie.

Get the gist?

innittowinit
23/1/2021
13:14
@ Onceaday There's nothing to back so what are you expecting - a declaration of support for a financing that hasn't even been approved in principle let alone structured? Another daft comment

BTW three more recent examples of bio/life-science co's whose share prices are materially ahead of their recent placing prices:

AGL share price now 75p vs placing @45p
DEST share price now 115p vs placing @65p
RUA share price now 175p vs placing @120p

t0pgrader
23/1/2021
13:09
My only recent experience of an AIM fundraise was ReNeuron. The shares dropped from above £1 a few weeks before to the open offer price of 70p. They have now recovered but I assume a similar scenario.

I don't understand why W. Health LP who own 47% of the stock are not being mentioned as backers.

onceaday
23/1/2021
12:55
@ EKCS no one wants to bother reading responses to innit's daft comments like his suggestion the reason why STX is engaging with lenders is because they cant fund the raise through equity when the opposite is the case to minimise shareholder dilution or his musing that there's going to be a rerating but it could be downwards; there's not a soul on this board or any other presenting an argument for a derating from this level. Get the gist?
t0pgrader
22/1/2021
16:06
Being the mug I am I've had a little top up, only because the Director has, he knows better than me. Gla
bobaxe1
Chat Pages: Latest  315  314  313  312  311  310  309  308  307  306  305  304  Older

Your Recent History

Delayed Upgrade Clock